Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
158.33 |
null |
4.59 |
11.24 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
371 |
days |
100789 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then enalapril (15 mg/l) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 6 |
201.08 |
null |
15.0 |
36.74 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
308 |
days |
100778 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
179.66 |
null |
2.47 |
6.05 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
371 |
days |
100791 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
control condition |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 5 |
212.59 |
null |
11.41 |
25.51 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
|
0 |
|
100779 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 6 |
182.12 |
null |
13.44 |
32.92 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
308 |
days |
100777 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
178.53 |
null |
22.47 |
55.04 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
371 |
days |
100790 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
control condition |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
212.59 |
null |
18.05 |
44.21 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
|
0 |
|
100793 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 371 days) then enalapril (15 mg/l) (for 63 days) and anti-transforming growth factor beta antibody (0.5 mg/kg/d) (for 63 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
427 days
| 6 |
201.84 |
null |
11.34 |
27.78 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
371 |
days |
100792 |
2522 |
Crl:SD |
number of podocytes per kidney glomerulus |
streptozotocin (60 mg/kg/d) then insulin (for 308 days) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (0.5 mg/kg/d) (for 175 days) |
Benigni A, et al., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10. |
podocyte morphology trait |
male |
364 days
| 6 |
158.59 |
null |
4.58 |
11.22 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
0.0 |
stz |
308 |
days |
100776 |
2522 |